Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineTime to top-slice re-rated Judges Scientific
JUDGES SCIENTIFIC (JDG:AIM) £50.50
Gain to date: 77.2%
Original entry point: Buy at £28.50, 11 April 2019
A near-80% gain in a few short years would be impressive, but to do it in just a handful of months takes luck as well as good judgement.
Yet this is what’s happened to the performance of Judges Scientific (JDG:AIM) since we highlighted its attractions in April.
The company is a portfolio of niche science-based businesses spanning nanotechnology, fibre optic testing, advanced materials, LED design and x-ray technology.
We originally said it was a proven, high-quality business that was simply too cheap on a 2019 forecast price-to-earnings multiple of 14.8. We saw very good re-rating opportunity and so it has come to pass.
This is in part thanks to September’s record half-year results that set new high bars for revenue, adjusted pre-tax profit, earnings per share, cash generation and dividends, but also for management’s upbeat comments which put to bed investor concerns about an economic slowdown.
The re-rating leaves the stock trading on 24.3 times next year’s expected earnings. Investors taking a multi-year view should stay with the story, but for those with more immediate priorities, this may be a prudent time to top slice profit and take some money off the table.
SHARES SAYS: Consider taking some profit.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
